New flu vaccine for the over 75s
Sharon Graham discusses what the latest government advice on age-related flu vaccinations means in practice.
The June 2017 Joint Committee on Vaccination and Immunisation (JCVI) commented on the trivalent inactivated influenza vaccine (TIV), saying that in those 18-64 years old, effectiveness of the vaccine was modest for all strains, but in those 65 years and over, TIV effectiveness was significantly lower.
The JCVI went on to say that the TIV effectiveness seen in in those 65 years and over was disappointing and that there was a trend for lower vaccine effectiveness against H3N2 in older people due potentially to immunosenescence (JCVI 2017a).
This news broke briefly in the national press without too much furore and it remains to be seen if it had an impact on the uptake for the 2017/18 season (BBC 2017).
For a number of years there...
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Primary Health Care
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests